Product Reports Resources Pricing Login Book a demo
Noubar Afeyan
Person deep dive

Noubar Afeyan

Noubar Afeyan is the founder and CEO of Flagship Pioneering, a Cambridge, Massachusetts firm that creates life sciences companies in-house. He co-founded Moderna, which listed on Nasdaq in 2018, and Flagship companies such as Generate Biomedicines, which listed in 2026.

Founded
Etcelera, Sail Biomedicines, Lila Sciences +35 more
Backed
Exact Sciences, T2 Biosystems, Cologuardtest +1 more
Education
Massachusetts Institute of Technology, McGill University

Track record

Companies Noubar Afeyan founded or backed, with what became of them.

Flagship Pioneering

FirmFlagship Pioneering
Founded2000
Based inCambridge, Massachusetts
Funds$3.6B raised in 2024; $14B under management
FocusCreates and builds life sciences companies from its own research

Career

  1. 1987Completes a PhD in biochemical engineering at MIT.
  2. 1988Founds PerSeptive Biosystems and runs it as CEO.
  3. 1998PerkinElmer buys PerSeptive Biosystems for about $360M.
  4. 2000Founds Flagship Pioneering, which starts companies from its own research.
  5. 2010Co-founds Moderna and becomes its chairman.
  6. 2018Moderna lists on Nasdaq and raises $621M.
  7. 2024Flagship raises $3.6B, taking assets under management to $14B.
  8. 2026Generate Biomedicines lists on Nasdaq and raises $400M.

Sources: Noubar Afeyan, Wikipedia · Moderna, Wikipedia · Flagship Pioneering raises $3.6 billion (Flagship, 2024) · Generate's IPO raises $400M (pharmaphorum) · Noubar Afeyan, Dealroom.

Investments 4

Companies backed, as recorded by Dealroom. Highest company valuations first.

Companies founded

Etcelera
Founder · 2026 – present
Sail Biomedicines
Founder · 2023 – present
Unicorn
Lila Sciences
Founder · 2022 – present
$1.3B valuation (2025)Unicorn
→
Montai Health
Board Member · Founder · 2022 – 2023
$300M valuation (2022)
→
Abiologics
Founder · 2020 – present
$300M valuation (2024)
→
Ampersand Biomedicines
Founder · 2020 – present
$390M valuation (2025)
→
Apriori Bio
Chairman · Founder · 2020 – present
$300M valuation (2022)
→
Generate Biomedicines
Chairman · Founder · 2020 – present
$1.6B valuation (2026)Unicorn
→
Repertoire Immune Medicines
Board Member · Founder · 2020 – 2021
$1.1B valuation (2021)
→
Tessera Therapeutics
Board Member · Founder · 2018 – present
$1.5B valuation (2025)Unicorn
→
Sana Biotechnology
Board Member · Founder · 2018 – 2020
$603.8M valuation (2026)Unicorn
→
Cellarity
Chairman · Founder · 2017 – 2021
$726M valuation (2022)
→
Laronde
Chairman · Founder · 2017 – 2022
$2.6B valuation (2021)
→
Omega Therapeutics
Founder · 2017 – 2023
→
Ring Therapeutics
Chairman · Founder · 2017 – 2021
$585M valuation (2023)
→
Cygnal Therapeutics
Board Member · Founder · 2016 – present
$390M valuation (2019)
→
Inari
Founder · 2016 – present
$2.2B valuation (2025)Unicorn
→
CiBO Technologies
Board Member · Founder · 2015 – 2017
$180M valuation (2021)
→
Codiak Biosciences
Board Member · Founder · 2015 – 2017
$876.5K valuation (2023)
→
Evelo Biosciences (Formerly Evelo Therapeutics, VL28)
Founder · 2015 – 2019
→
Kaleido Biosciences
Board Member · Founder · 2015 – 2019
→
Torque Therapeutics
Board Member · Founder · 2015 – 2021
$150M valuation (2017)
→
Indigo
Board Member · Founder · 2013 – present
$3.5B valuation (2020)Unicorn
→
Rubius Therapeutics
Board Member · Founder · 2013 – 2022
$5.2M valuation (2024)Unicorn
→
Moderna Therapeutics
Founder · 2010 – present
$90.4B valuation (2026)Decacorn
→
Axcella
Founder · 2010 – 2018
$1.2M valuation (2024)
→
Seres Therapeutics
Board Member · Founder · 2010 – 2020
$14.3M valuation (2026)
→
Joule Unlimited
Chairman · Founder · 2007 – 2017
$300M valuation (2013)
→
LS9
Board Member · Founder · 2005 – present
$61.5M valuation (2014)
→
Codon Devices
Chairman · Founder · 2004 – 2007
→
Helicos BioSciences
Board Member · Founder · 2003 – 2011
→
Adnexus
Board Member · Founder · 2002 – 2008
$430M valuation (2007)
→
Ensemble Therapeutics
Chairman · Founder · 2002 – 2016
$90M valuation (2007)
→
Selventa
Board Member · Founder · 2002 – 2007
$39M valuation (2003)
Flagship Pioneering
CEO · Founder · 2000 – present
→
Affinnova
Board Member · Founder · 2000 – 2014
$35.6M valuation (2003)
→
BG Medicine
Board Member · Founder · 2000 – 2016
$546K valuation (2026)
→
Sequana Therapeutics
Founder · 1998 – 1999

Currently

Active roles, board seats and partnerships.

Profound Therapeutics
Founding Chairman · 2021 – present
$450M valuation (2022)
→
Massachusetts Institute of Technology
Member of Executive Committee · 2016 – present
MIT-IBM Watson AI Lab
2016 – present
Boston Symphony Orchestra
Board Member · 2008 – present
Thermo Fisher Scientific
1998 – present
$259B valuation (2026)
→
Agenus
$304.5M valuation (2026)
→
Permeon Biologics
$15M valuation (2011)
PerSeptive Biosystems

Work history

Past roles by Dealroom records.

Alltrna
Founding Chairman · 2018 – 2023
$654M valuation (2023)
→
Harvard Business School
Visiting Lecturer · 2018 – 2020
Valo Health
Chairman · 2018 – 2020
$950M valuation (2021)Unicorn
→
Ohanabio
Board Member · 2016 – 2018
AGBU
Board Member · 2014 – 2018
Skoltech | Skolkovo Institute of Science and Technology
Board Member · 2012 – 2014
BIND Therapeutics
Board Member · 2007 – 2014
→
BU Today
Board of Overseers Member · 2007 – 2010
Moscow School of Management SKOLKOVO
Board Member · 2007 – 2012
T2 Biosystems
Board Member · Investor · 2006 – 2009
$5.3M valuation (2025)
→
MIT Sloan School of Management
Senior Lecturer · 2000 – 2016
LifeTechnologies
Chief Business Officer · 1998 – 1999
$13.6B valuation (2014)
Color Kinetics, Incorporated
Board Member · Investor · 1997 – 2008
→
Cologuardtest
Board Member · Investor · 1995 – 2001
Exact Sciences
Board Member · Investor · 1995 – 2001
$23B valuation (2026)Decacorn
→

Education

Massachusetts Institute of Technology
PhD · 1983 – 1987
McGill University
Bachelor · Chemical Engineering · 1980 – 1983
← All people